ACP
TNDM icon

Acuta Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History

Acuta Capital Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,346,360
Closed -$6.68M – 73
2018
Q1 		$6.68M Buy
+1,346,360
New +$4.34M 1.09% 19

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acuta Capital Partners's TNDM Position: Q2 2018 in Review

Acuta Capital Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2018, closing a stake of 1,346,360 shares — an estimated $6.68M sold.

Acuta Capital Partners first reported a position in TNDM in Q1 2018 and held it in 1 quarter. The position peaked at $6.68M in Q1 2018. 116 funds tracked by Wall St. Rank hold TNDM as of Q2 2018.

  • Acuta Capital Partners reported no remaining Tandem Diabetes Care position as of Q2 2018 after selling out during the quarter.
  • Acuta Capital Partners sold 1,346,360 Tandem Diabetes Care shares in Q2 2018, an estimated $6.68M.
  • Acuta Capital Partners first reported a position in Tandem Diabetes Care in Q1 2018 and held it in 1 quarter.
  • Acuta Capital Partners's Tandem Diabetes Care position peaked at $6.68M in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2018.

Based on Acuta Capital Partners's 13F filing for Q2 2018, filed 15 Aug 2018.